Evan Brower is an experienced professional in the field of biotechnology and pharmaceuticals, currently serving as the Director of CMC at Elusys Therapeutics, Inc. Previously, Evan held positions at NextCure, Inc. as Director of Technology Transfer and Associate Director of Process Development. Additionally, Evan worked at Catalent Pharma Solutions, advancing from Senior Manager of Manufacturing Sciences & Technology to Manager and Senior Scientist, while also serving as a Supervisor and Principal Investigator. Early in Evan's career, experience was gained at Johns Hopkins School of Medicine as a Postdoctoral Fellow and at Johns Hopkins University as a Graduate Research Assistant. Evan earned a Ph.D. in Biology from The Johns Hopkins University and a BS in Microbiology from the University of Illinois Urbana-Champaign.